SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

EMS Find Inc (OTCMKTS:EMSF) released a PR to alert the markets about a mailer named as “The Moskowitz Report.” The company warned that the report is being circulated by third parties which are not affiliated or engaged by the Company. The report is prepared to promote the company’s common stock.

The update

EMS Find stated that the campaign was not authorized by the Company. The directors, officers or any of company’s controlling shareholders have not indirectly or directly been involved in the promotion or compensation paid to third parties. There is no connection of them with the distribution or creation of this promotional content related to EMS Find and its securities. Also, the company, its directors, officers or any controlling shareholders have not bought or sold EMS’s securities in the markets in past one month.

The CEO statement

Steve Rubakh, the CEO of EMS Find, commented that the company is concerned about ongoing measures carried out by persons outside the company aimed at promoting the market for company’s common stock. Mr. Rubakh said that management advises to potential investors and existing shareholders that EMS Find does not run promotional campaigns to promote the market for company’s securities. Also, they do not approve third party promotional campaigns on behalf of the firm.

The progress

In unrelated news, EMS Find Inc (OTCMKTS:EMSF) announced that it retained Meister, Seelig & Fein, LLP so that it can file a provisional patent request with the U.S. Patent and Trademark Office for its “on-demand mobile” medical transport solution. It is a unique platform where the different entities like consumers and healthcare providers can schedule transports as per their individual requirement. It will help them to save the critical resources including time and money.

The stock gained 4.35% to close at $1.20 in yesterday’s trading session. The stock has a market capitalization of $33.90 million with 28.25 million outstanding shares.